RT Journal
A1 Katz MH
T1 Time to stop screening for prostate cancer : Comment on “declines in prostate cancer incidence after changes in screening recommendations”
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD September 10
VO 172
IS 16
SP 1268
OP 1268
DO 10.1001/archinternmed.2012.3000
UL http://dx.doi.org/10.1001/archinternmed.2012.3000
AB 
Over the last decade, the evidence that screening for prostate cancer causes more harm than good has grown so much that the US Preventive Services Task Force recommended in 2008 against screening for prostate cancer in men 75 years or older, and more recently, recommended against screening men of any age. The data in the Research Letter by Howard suggest that many physicians agree with the recommendation not to screen older men. Given that the harms of screening (eg, false-positive results, increased worry, treatment-related morbidities such as incontinence and erectile dysfunction) outweigh the benefits for younger men as well, we hope to see a similar decrease in early prostate cancer incidence in young men.